AppBrain's verdict
- Rating on App Store
- 5.00
- 5 ratings
- Last updated
- June 25, 2026
- Size
- 36.7 MB
It doesn't have enough ratings yet to judge what users think.
User feedback
Ratings and reviews on the App StoreComments on Biotech Pulse for iOS
We don't have enough comments to show example comments. Please check back later.
Store listing
By MEAS Partners, LLC, from the App StoreDescription by MEAS Partners, LLC Written by the developer, not by AppBrain. Click to read.
WHO IT'S FOR
Biotech investors, pharma analysts, healthcare hedge funds, and retail traders who need to see what just happened on a name BEFORE the wire-service summary hits Twitter.
FREE FEATURES (no account, no signup)
• Real-time FDA approval, PDUFA, CRL, and Warning Letter alerts
• EU EMA marketing authorisation feed (UK + EEA centralised approvals)
• SEC 8-K filings, press releases, and clinical trial updates
• Forward catalyst calendar with PDUFA, AdCom, and CHMP dates
• Push notifications when a watchlisted ticker has an event
• Watchlist + per-ticker News, Pipeline, Drugs, Intelligence tabs
• Indication / drug-class search ("multiple sclerosis", "GLP-1", "CAR-T")
• Drug detail with FAERS adverse-event severity and primary-source link to Drugs@FDA
• Watchlist Compare view — side-by-side pipeline depth + next catalyst
BIOTECH PULSE PRO ($9.99/mo or $79.99/yr, with 7-day free trial)
Twelve institutional-grade Pro features, every one sourced from a primary regulatory or scientific feed:
• Insider buys — SEC Form 4 executive open-market purchases, 10b5-1 plans filtered out
• 13F institutional holdings — quarterly changes, biotech-whale callouts (Baker Bros, BVF, RA Capital, Perceptive)
• 8-K dilution radar — automatic offering / shelf / ATM classification
• 8-K Item 8.01 content classifier — CRL, PDUFA, AdCom, trial readout, partnership, regulatory filing categories
• Material agreements — 8-K Item 1.01 partnership / licensing / supply detection
• AdCom calendar — Federal Register FDA Advisory Committee meetings + briefing-doc URLs
• Orange Book + USPTO patent timelines — every unexpired patent with USPTO Patent Term Adjustment chips (PTA extends patent expiry past the Orange Book listing — the most under-priced biotech signal), Re-exam warning flags, family-size hints, and one-tap to the patent document on Google Patents
• FDA Warning Letter history
• FDA device clearances — 510(k) and PMA by manufacturer
• DailyMed label history — every SPL version bump (indication, black-box, REMS)
• CMS Open Payments — KOL payment network per sponsor
• CMS Part D utilization — 5 years of Medicare prescription volume
• Drug shortages — FDA-tracked active shortages with push alerts on status changes
• Conference abstracts — ASH, ASCO, AHA, AAN, DDW
• Custom alert rules — unlimited, all 4 trigger types including 8-K Item filtering
100% PRIMARY-SOURCE DATA
SEC EDGAR. openFDA. EMA. CHMP. Health Canada. CMS. NIH. Federal Register. ClinicalTrials.gov. DailyMed. USPTO. ash.confex.com. No Bloomberg, no Refinitiv, no FactSet, no paid data vendors. No AI hallucinations. No analyst recommendations. Just the data.
NO TRACKING
No analytics SDK. No advertising SDK. No cross-app tracking. No account required. External article links open in Safari's isolated process. We don't know who you are.
Pro auto-renews unless cancelled at least 24 hours before the end of the current period. Cancel anytime in iOS Settings → Apple ID → Subscriptions.
Terms of Use: https://bioturd.com/terms
Privacy Policy: https://bioturd.com/privacy
Safety and technology
Found in the app by AppBrain- Price
- Free
- App size
- 36.7 MB
- Content rating
- Everyone
Technologies used by Biotech Pulse
Releases
Updates seen on the App Store- Version
- 1.1.3
- Launched
- April 2026
No changelog data
Alternatives
Similar apps and more from MEAS Partners, LLCMore from MEAS Partners, LLC
Rankings
App Store top chartsApp Store Rankings for Biotech Pulse
About the app and developer
About Biotech Pulse
Biotech Pulse is a finance app developed by MEAS Partners, LLC.
User Ratings
Biotech Pulse is rated 5.00 out of 5 stars. The rating is based on 5 ratings.
App Information
Biotech Pulse is freely available from the App Store. The app size is 36.66 MB. The latest version available is 1.1.3. The last update was on June 25, 2026.
Technical Requirements
The app has a content rating of Everyone. The app has been available on the App Store since April 2026.
Biotech Pulse is made and published by MEAS Partners, LLC. AppBrain is an independent app data site and isn't affiliated with MEAS Partners, LLC. The app name, icon, screenshots and description belong to MEAS Partners, LLC and are shown as published on the App Store.
Developer information for MEAS Partners, LLC
Address:
Frequently asked questions about Biotech Pulse
Is Biotech Pulse free?
Yes. Biotech Pulse is free on the App Store.
Is Biotech Pulse still available?
Yes. Biotech Pulse is on the App Store, and the last update we saw was on June 25, 2026.
How large is Biotech Pulse?
Biotech Pulse is 36.66 MB.
Is Biotech Pulse suitable for children?
App Store rates the content of Biotech Pulse as suitable for everyone.
How do people rate Biotech Pulse?
Biotech Pulse scores 5.00 out of 5 stars, from 5 ratings on the App Store.
Who made Biotech Pulse?
Biotech Pulse was developed by MEAS Partners, LLC. It is listed in the finance category on the App Store.
Share Biotech Pulse
Subscribe now to get full and unlimited access to AppBrain Intelligence. You'll have access to:
- App Intelligence dashboard (performance timeline, competitor comparison, country rankings, insight cards)
- Detailed ranking data per app
- Full timeline per developer
- Device market shares data per country
- Unlimited keyword tracking
AppBrain is an app data site, we track rankings, ratings, installs for all apps and games on Google Play and the App Store. AppBrain doesn't host app files or APKs, all install links go directly to the official store. All trademarks are owned by their respective owners.
More apps
App statistics